FDA
approval
· 2015-11-06
FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved a supplemental application for Rizatriptan Benzoate by Teva Pharmaceuticals USA, Inc., approving an updated indication/label for this migraine trea…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)